CNR2 and Alzheimer disease: In this sense, it is important to note that disease-linked symptoms in 5xFAD mice are not evident before 6 months of age; thus, the induction of the cnr2 gene expression is previous to phenotypic changes due to amyloid pathology, indicating that CB2R may provide diagnostic and therapeutic targets for the treatment of early stage AD [28].